Ryan Gerbrandt - Jan 16, 2025 Form 4 Insider Report for Anterix Inc. (ATEX)

Signature
s/ Gena L. Ashe, Attorney-in-Fact
Stock symbol
ATEX
Transactions as of
Jan 16, 2025
Transactions value $
$0
Form type
4
Date filed
1/21/2025, 05:24 PM
Previous filing
Oct 8, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares subject to this option vest and become exercisable in three equal annual installments with vesting commencing on January 16, 2025, subject to the Reporting Person's continuous service to the Issuer through each such vesting date.